SCHEMBL14927010

SCHEMBL14927010

Cc1cc2cc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)nc(N=C(N)N)c2cc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLAU P00749 5/20 0.47
▸ PLG P00747 2/20 0.47
▸ NPFFR1 Q9GZQ6 1/20 0.42
▸ NPFFR2 Q9Y5X5 1/20 0.42
▸ KMT2A Q03164 5/20 0.40
▸ MEN1 O00255 4/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ POLB P06746 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ PKM P14618 1/20 0.40
▸ RAD52 P43351 4/20 0.39
▸ HTT P42858 1/20 0.37
▸ MPO P05164 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ QRFPR Q96P65 1/20 0.37
▸ ATP4A P20648 1/20 0.37
▸ ATP4B P51164 1/20 0.37
▸ ADORA3 P0DMS8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14927013 0.94 PLAU (0.49) PLAUPLGNPFFR1NPFFR2KMT2A
SCHEMBL12070672 0.84 ACACA (0.47) PLAUPLGKMT2AMEN1ALDH1A1
SCHEMBL12070766 0.78 ACACA (0.49) PLAUPLGKMT2AMEN1ALDH1A1
SCHEMBL14927078 0.75 L3MBTL1 (0.47) KMT2AMEN1ALDH1A1KDM4EPOLB
SCHEMBL14927020 0.73 GRIN2D (0.41) PLAUPLGNPFFR1NPFFR2ALDH1A1
SCHEMBL14927007 0.72 MEN1 (0.43) KMT2AMEN1ALDH1A1KDM4EPOLB
SCHEMBL14927008 0.70 LMNA (0.43) KMT2AMEN1ALDH1A1KDM4EPOLB
SCHEMBL14927105 0.70 RAC1 (0.47) KMT2AMEN1ALDH1A1KDM4EPOLB
SCHEMBL130007 0.69 RAC1 (0.49) KMT2AMEN1ALDH1A1KDM4EPOLB
SCHEMBL14927081 0.68 L3MBTL1 (0.46) KMT2AMEN1ALDH1A1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933096-B2 Antimicrobial agents Rugers, The State University of New Jersey (US) 2015-01-13 — — US disclosed
US-20130116278-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116278-A1 ANTIMICROBIAL AGENTS MRPL21, ARG1, RPP30 PLAU 4639/4885PLG 4846/4885NPFFR1 400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback